The Biden Administration will fine the drug manufacturers of 27 medicines for sharp price increases. The FDA approves Pfizer’s bivalent COVID booster for children as young as six months. And, the FDA says that Paxlovid is not responsible for rebound infections of COVID-19 ahead of an advisory committee meeting. That’s coming up on today’s episode of Gist Healthcare Daily.

Hosted on Acast. See acast.com/privacy for more information.